GlassScriptPhysician profile
Srinivas Kumar Rumalla
NPI 1184648701
$3,689.28
in general payments reported to CMS, 2019-2025
33 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $233 · 2021: $610 · 2022: $755 · 2023: $670 · 2024: $377 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $777.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $516.44 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $279.88 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Sanofi-Aventis U.S. LLC | $276.95 | 2019-2023 | |
| Glaxosmithkline, LLC. | $252.98 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.28 | 2019-2024 | Synjardy, Jardiance, Tradjenta |
| Abbott Laboratories | $161.57 | 2021-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $129.69 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $127.47 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $113.79 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Otsuka America Pharmaceutical, INC. | $112.56 | 2023 | Rexulti |
| Abbvie INC. | $98.98 | 2021-2023 | Dalvance, Avycaz |
| Janssen Pharmaceuticals, INC | $93.94 | 2019-2023 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $92.84 | 2021-2022 | |
| Amarin Pharma, INC. | $56.60 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $42.79 | 2019 | |
| Amgen INC. | $39.73 | 2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $39.38 | 2022 | |
| Xeris Pharmaceuticals, INC. | $24.80 | 2023 | Gvoke Hypopen |
| Phathom Pharmaceuticals, INC. | $24.17 | 2024 | Voquezna |
| Esperion Therapeutics, INC. | $22.73 | 2021 | |
| Seqirus USA INC | $18.50 | 2025 | Flucelvax, Fluad |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.86 | 2023 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $17.67 | 2023 | Gattex |
| Phadia US INC. | $17.48 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.35 | 2019 | |
| Shire North American Group INC | $17.34 | 2019 | |
| Medtronic Vascular, INC. | $16.43 | 2019 | |
| Shield Therapeutics INC | $16.07 | 2023 | Accrufer |
| Eisai INC. | $13.67 | 2021 | |
| Philips North America LLC | $13.53 | 2022 | |
| Scilex Pharmaceuticals INC. | $11.41 | 2019 | |
| Astellas Pharma US INC | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Rumalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.